John C. Lechleiter
2012
In 2012, John C. Lechleiter earned a total compensation of $14.6M as Chairman, President, and Chief Executive Officer at Lilly Eli & Co, a 11% decrease compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $4,423,633 |
|---|---|
| Non-Equity Incentive Plan | $2,982,000 |
| Salary | $1,500,000 |
| Stock Awards | $5,625,000 |
| Other | $90,000 |
| Total | $14,620,633 |
Lechleiter received $5.6M in stock awards, accounting for 38% of the total pay in 2012.
Lechleiter also received $4.4M of change in pension value and nonqualified deferred compensation earnings, $3M in non-equity incentive plan, $1.5M in salary and $90K in other compensation.
Rankings
In 2012, John C. Lechleiter's compensation ranked 190th out of 11,487 executives tracked by ExecPay. In other words, Lechleiter earned more than 98.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 190 out of 11,487 | 98th |
Division Manufacturing | 75 out of 4,253 | 98th |
Major group Chemicals And Allied Products | 16 out of 1,198 | 99th |
Industry group Drugs | 10 out of 920 | 99th |
Industry Pharmaceutical Preparations | 8 out of 700 | 99th |
Source: SEC filing on March 23, 2015.
Lechleiter's colleagues
We found four more compensation records of executives who worked with John C. Lechleiter at Lilly Eli & Co in 2012.
2012
Derica Rice
Lilly Eli & Co
Chief Financial Officer
2012
Jan Lundberg
Lilly Eli & Co
Executive Vice President, Science and Technology and President, Lilly Research Laboratories
2012
Robert Armitage
Lilly Eli & Co
General Counsel
2012
Enrique Conterno
Lilly Eli & Co